7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 
      
    		                                
      assets
    		                                
      current assets
    		                                
      cash and cash equivalents
    		43,523,000 61,738,000 67,894,000 86,952,000 85,035,000 93,671,000 96,958,000 62,838,000 38,685,000 41,705,000 31,463,000 53,922,000 65,572,000 84,484,000 106,671,000 146,256,000 107,796,000 131,737,000 22,171,000 102,562,000 85,127,000 29,772,000 34,652,000 109,892,000 39,116,000 30,289,000 54,367,000    49,570,000  
      accounts receivable
    		50,435,000 47,709,000 47,454,000 47,682,000 44,642,000 43,149,000 34,240,000 30,529,000 30,464,000 28,996,000 23,455,000 22,448,000 20,920,000 21,026,000 16,800,000 14,657,000 13,289,000 11,864,000 7,816,000 9,680,000 11,399,000 8,649,000 10,406,000 10,661,000 7,206,000 1,410,000       
      inventories
    		32,871,000 26,457,000 10,026,000 12,158,000 14,892,000 13,381,000 11,547,000 10,998,000 17,626,000 19,859,000 23,418,000 18,852,000 21,565,000 12,289,000 3,615,000 1,762,000 3,816,000 3,337,000 2,775,000 3,354,000 4,871,000 10,343,000 12,542,000 6,407,000 10,043,000 11,522,000 2,578,000      
      prepaid expenses
    		4,604,000 4,792,000 3,452,000 3,349,000 3,399,000 5,507,000 5,678,000 5,700,000 3,655,000 4,297,000 4,159,000 3,902,000 3,656,000 4,724,000 4,533,000 5,082,000 4,484,000 5,737,000 5,464,000              
      other current assets
    		3,456,000 4,274,000 2,892,000 1,201,000 2,393,000 2,426,000 1,842,000 2,356,000 1,569,000 1,603,000 1,590,000 1,678,000 4,233,000 11,424,000 11,309,000 11,042,000 8,959,000 9,215,000 6,728,000              
      total current assets
    		134,889,000 144,970,000 131,718,000 151,342,000 150,361,000 158,134,000 150,265,000 112,421,000 91,999,000 96,460,000 84,085,000 100,802,000 115,946,000 133,947,000 142,928,000 178,799,000 138,344,000 161,890,000 77,717,000 127,612,000 132,400,000 107,998,000 126,142,000 152,197,000 95,184,000 115,826,000 139,084,000 94,339,000 106,092,000 44,623,000 50,111,000 72,824,000 
      property and equipment
    		5,131,000 3,653,000 3,254,000 3,222,000 2,314,000 2,284,000 2,088,000 2,087,000 2,130,000 2,353,000 2,595,000 2,616,000 1,882,000 1,455,000 1,303,000 1,371,000 1,058,000 1,137,000 1,217,000 1,297,000 1,362,000 1,422,000 1,433,000 902,000 984,000 290,000   1,000 5,000   
      operating lease right-of-use assets
    		7,468,000 7,827,000 6,922,000 7,185,000 8,280,000 5,462,000 5,615,000 5,763,000 5,907,000 1,523,000 1,738,000 1,947,000 2,149,000 2,346,000 2,537,000 2,722,000 2,902,000 3,078,000 3,248,000 3,414,000 3,578,000 3,738,000 3,899,000 4,068,000 4,238,000 5,040,000 810,000      
      intangible assets
    		48,719,000 49,347,000 49,359,000 48,754,000 46,587,000 46,275,000 46,591,000 47,110,000 46,505,000 47,216,000 47,927,000 48,597,000 49,108,000 49,415,000 50,032,000 50,625,000 51,468,000 52,310,000 53,568,000 55,297,000 56,791,000 58,023,000 59,174,000 59,638,000 59,857,000 59,211,000 58,782,000      
      goodwill
    		21,208,000 21,208,000 21,208,000 21,208,000 21,208,000 21,208,000 21,208,000 21,208,000 21,208,000 21,208,000 21,208,000 21,208,000 21,208,000 21,208,000 21,208,000 21,208,000 21,208,000 21,208,000 21,208,000 21,208,000 21,208,000 21,208,000 21,208,000 21,208,000 21,208,000 21,208,000 21,208,000 21,208,000 21,208,000 21,208,000 21,208,000 21,208,000 
      other assets
    		1,582,000 1,798,000 900,000 858,000 858,000 409,000 409,000 409,000 222,000 223,000 2,682,000 2,813,000 2,426,000 2,548,000 2,654,000 2,758,000 240,000 240,000 240,000 240,000 440,000 2,155,000 2,295,000 2,429,000 1,195,000 1,206,000 1,045,000 221,000  22,000  2,125,000 
      total assets
    		218,997,000 228,803,000 213,361,000 232,569,000 229,608,000 233,772,000 226,176,000 188,998,000 167,971,000 168,983,000 160,235,000 177,983,000 192,719,000 210,919,000 220,662,000 257,483,000 215,220,000 239,863,000 157,198,000 209,068,000 215,779,000 194,544,000 214,151,000 240,442,000 182,666,000 202,781,000 220,929,000 171,844,000 183,377,000 121,934,000 127,395,000 152,233,000 
      liabilities and stockholders’ equity
    		                                
      current liabilities
    		                                
      accounts payable
    		22,958,000 23,312,000 16,176,000 9,236,000 13,836,000 10,281,000 11,216,000 4,271,000 11,760,000 7,835,000 10,185,000 8,935,000 8,564,000 10,486,000 7,565,000 6,091,000 7,365,000 8,059,000 13,253,000 9,615,000 2,957,000 10,952,000 10,699,000 5,796,000 6,125,000  1,863,000 1,558,000 661,000 751,000 547,000 445,000 
      accrued expenses
    		30,462,000 27,949,000 26,619,000 40,791,000 34,949,000 32,790,000 25,054,000 33,813,000 26,713,000 24,184,000 22,109,000 24,794,000 29,883,000 28,537,000 21,139,000 29,993,000 23,436,000 24,357,000 12,567,000 9,102,000 6,425,000 6,094,000 9,403,000 13,960,000 14,378,000  6,735,000 3,718,000 4,799,000 2,933,000 2,352,000 977,000 
      current portion of operating lease liabilities
    		2,476,000 2,392,000                        1,031,000       
      current portion of contingent royalty obligation payable to evolus founders
    		10,815,000 10,097,000                               
      total current liabilities
    		66,711,000 63,750,000 56,233,000 62,960,000 60,815,000 54,118,000 46,801,000 48,291,000 48,540,000 41,349,000 40,678,000 46,509,000 51,271,000 51,531,000 40,700,000 57,663,000 71,303,000 87,286,000 87,648,000 180,248,000 12,709,000 19,462,000 22,613,000 24,439,000 25,974,000 23,105,000 9,400,000 5,276,000 5,460,000 3,684,000 3,629,000 212,748,000 
      long-term portion of operating lease liabilities
    		6,636,000 7,039,000                               
      long-term portion of contingent royalty obligation payable to evolus founders
    		25,878,000 28,489,000                               
      long-term portion of term loan, net of discount and issuance costs
    		145,780,000 145,475,000                               
      contingent milestone payment
    		2,752,000 2,681,000 2,416,000 2,270,000                             
      deferred tax liability
    		 21,000 2,000 6,000 29,000 29,000 32,000 27,000 22,000 22,000 22,000 22,000 25,000 29,000 23,000 40,000 25,000 25,000 25,000 25,000 179,000 190,000 256,000  156,000 305,000 533,000 15,055,000 15,031,000 15,013,000 15,000,000 14,990,000 
      total liabilities
    		247,757,000 247,455,000 219,965,000 227,047,000 223,718,000 214,458,000 207,733,000 209,687,000 187,339,000 175,946,000 153,286,000 159,484,000 163,499,000 164,058,000 153,414,000 175,607,000 117,816,000 133,725,000 133,909,000 282,026,000 180,684,000 150,941,000 151,545,000 160,985,000 165,623,000 161,600,000 145,572,000 87,460,000 88,411,000 83,999,000 75,413,000 227,776,000 
      commitments and contingencies
    		                                
      stockholders’ equity
    		                                
      preferred stock, 0.00001 par value; 10,000,000 shares authorized; no shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively
    		                                
      common stock
    		1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000  
      additional paid-in capital
    		632,546,000 627,379,000 622,525,000 615,825,000 609,186,000 603,352,000 591,087,000 538,716,000 528,385,000 523,729,000 519,449,000 516,129,000 513,717,000 510,879,000 507,733,000 504,757,000 502,108,000 491,409,000 392,959,000 303,113,000 300,469,000 297,502,000 295,174,000 292,509,000 215,574,000 212,704,000 209,365,000 207,408,000 205,548,000 136,687,000 134,301,000  
      accumulated other comprehensive loss
    		-137,000 -599,000 -839,000 -905,000 -689,000 -601,000 -557,000 -427,000 -606,000 -468,000 -416,000 -337,000 -368,000 -165,000 -103,000            -9,000      
      accumulated deficit
    		-661,170,000 -645,433,000 -628,291,000 -609,399,000 -602,608,000 -583,438,000 -572,088,000 -558,979,000 -547,148,000 -530,225,000 -512,085,000 -497,294,000 -484,130,000 -463,854,000 -440,383,000 -422,882,000 -404,705,000 -385,272,000 -369,671,000 -376,072,000 -265,378,000 -253,919,000 -232,794,000 -213,059,000 -198,551,000 -171,567,000 -134,000,000 -123,025,000 -110,583,000 -98,753,000 -82,320,000 -75,543,000 
      total stockholders’ equity
    		-28,760,000 -18,652,000 -6,604,000 5,522,000 5,890,000 19,314,000 18,443,000 -20,689,000 -19,368,000 -6,963,000 6,949,000 18,499,000 29,220,000 46,861,000 67,248,000 81,876,000 97,404,000 106,138,000 23,289,000  35,095,000 43,603,000 62,606,000 79,457,000 17,043,000 41,181,000 75,357,000 84,384,000 94,966,000 37,935,000 51,982,000  
      total liabilities and stockholders’ equity
    		218,997,000 228,803,000 213,361,000 232,569,000 229,608,000 233,772,000 226,176,000 188,998,000 167,971,000 168,983,000 160,235,000 177,983,000 192,719,000 210,919,000 220,662,000 257,483,000 215,220,000 239,863,000 157,198,000  215,779,000 194,544,000 214,151,000 240,442,000 182,666,000 202,781,000 220,929,000 171,844,000 183,377,000 121,934,000 127,395,000  
      preferred stock, 0.00001 par value; 10,000,000 shares authorized; no shares issued and outstanding as of june 30, 2025 and december 31, 2024, respectively
    		                                
      operating lease liabilities
    		  1,967,000 1,718,000 1,601,000 1,041,000 1,152,000 1,377,000 1,363,000 1,349,000 1,334,000 1,320,000 1,307,000 1,293,000 1,279,000 1,265,000 1,252,000 1,239,000 1,226,000 1,212,000 1,197,000 1,182,000 1,195,000 1,200,000 1,148,000 4,147,000 802,000      
      contingent royalty obligation payable to evolus founders
    		  11,471,000 11,215,000 10,429,000 10,006,000 9,379,000 8,830,000 8,704,000 7,981,000 7,050,000 6,460,000 6,517,000 6,215,000 5,717,000 5,314,000 4,300,000 3,983,000 3,985,000 3,446,000 2,130,000 1,234,000 1,316,000 3,483,000 4,323,000 43,773,000       
      term loan, net of discount and issuance costs
    		  121,807,000 121,506,000 121,208,000 120,918,000 120,636,000 120,359,000 95,094,000 94,829,000 72,046,000 71,879,000 71,712,000 71,545,000 71,381,000     74,384,000             
      preferred stock, 0.00001 par value; 10,000,000 shares authorized; no shares issued and outstanding at march 31, 2025 and december 31, 2024, respectively
    		                                
      preferred stock, 0.00001 par value; 10,000,000 shares authorized; no shares issued and outstanding at december 31, 2024 and 2023, respectively
    		                                
      preferred stock, 0.00001 par value; 10,000,000 shares authorized; no shares issued and outstanding at september 30, 2024 and december 31, 2023, respectively
    		                                
      preferred stock, 0.00001 par value; 10,000,000 shares authorized; no shares issued and outstanding at june 30, 2024 and december 31, 2023, respectively
    		                                
      preferred stock, 0.00001 par value; 10,000,000 shares authorized; no shares issued and outstanding at march 31, 2024 and december 31, 2023, respectively
    		                                
      accrued litigation settlement
    		           5,000,000 5,000,000 5,000,000 5,000,000 15,000,000 15,000,000 30,000,000 30,000,000              
      preferred stock, 0.00001 par value; 10,000,000 shares authorized; no shares issued and outstanding at december 31, 2023 and december 31, 2022, respectively
    		                                
      preferred stock, 0.00001 par value; 10,000,000 shares authorized; no shares issued and outstanding at september 30, 2023 and december 31, 2022, respectively
    		                                
      preferred stock, 0.00001 par value; 10,000,000 shares authorized; no shares issued and outstanding at june 30, 2023 and december 31, 2022, respectively
    		                                
      preferred stock, 0.00001 par value; 10,000,000 shares authorized; no shares issued and outstanding at march 31, 2023 and december 31, 2022, respectively
    		                                
      preferred stock, 0.00001 par value; 10,000,000 shares authorized; no shares issued and outstanding at december 31, 2022 and december 31, 2021, respectively
    		                                
      preferred stock, 0.00001 par value; 10,000,000 shares authorized; no shares issued and outstanding at september 30, 2022 and december 31, 2021, respectively
    		                                
      preferred stock, 0.00001 par value; 10,000,000 shares authorized; no shares issued and outstanding at june 30, 2022 and december 31, 2021, respectively
    		                                
      preferred stock, 0.00001 par value; 10,000,000 shares authorized; no shares issued and outstanding at march 31, 2022 and december 31, 2021, respectively
    		                                
      short-term investments
    		                   5,000,000 24,996,000 54,982,000 64,987,000 19,911,000 34,913,000 69,640,000 79,313,000      
      promissory note payable to evolus founders
    		                19,950,000 19,648,000 19,354,000              
      convertible note
    		                   40,506,000 40,203,000            
      preferred stock, 0.00001 par value; 10,000,000 shares authorized; no shares issued and outstanding at december 31, 2021 and december 31, 2020, respectively
    		                                
      term loan, net of discounts and issuance costs
    		                    73,974,000            
      preferred stock, 0.00001 par value; 10,000,000 shares authorized; no shares issued and outstanding at september 30, 2021 and december 31, 2020, respectively
    		                                
      preferred stock, 0.00001 par value; 10,000,000 shares authorized; no shares issued and outstanding at june 30, 2021 and december 31, 2020, respectively
    		                                
      consideration receivable from daewoong
    		                  25,500,000              
      withholding tax receivable
    		                  7,263,000              
      withholding tax payable
    		                  7,263,000              
      preferred stock, 0.00001 par value; 10,000,000 shares authorized; no shares issued and outstanding at march 31, 2021 and december 31, 2020, respectively
    		                                
      prepaid expenses and other current assets
    		                   7,016,000 6,007,000 4,252,000 3,555,000 5,326,000 3,906,000 2,965,000 2,826,000 1,177,000 924,000 1,038,000 541,000 185,000 
      liabilities and stockholders’ (deficit) equity
    		                                
      accrued litigation settlement expenses
    		                   63,421,000             
      contingent promissory note payable to evolus founders
    		                   19,068,000 18,779,000 18,495,000 18,218,000 17,945,000 17,674,000 17,408,000       
      stockholders’ (deficit) equity
    		                                
      preferred stock, 0.00001 par value; 10,000,000 shares authorized; no shares issued and outstanding at december 31, 2020 and december 31, 2019, respectively
    		                                
      accumulated other comprehensive gain
    		                    3,000 19,000 225,000 6,000 19,000 43,000       
      total stockholders’ (deficit) equity
    		                   -72,958,000             
      total liabilities and stockholders’ (deficit) equity
    		                   209,068,000             
      preferred stock, 0.00001 par value; 10,000,000 shares authorized; no shares issued and outstanding at september 30, 2020 and december 31, 2019, respectively
    		                                
      long-term debt, net of discounts and issuance costs
    		                     74,165,000 73,841,000 73,508,000 73,180,000 72,862,000 72,557,000      
      preferred stock, 0.00001 par value; 10,000,000 shares authorized; no shares issued and outstanding at june 30, 2020 and december 31, 2019, respectively
    		                                
      preferred stock, 0.00001 par value; 10,000,000 shares authorized; no shares issued and outstanding at march 31, 2020 and december 31, 2019, respectively
    		                                
      deferred rent
    		                           25,000 29,000 32,000 35,000 38,000 
      preferred stock, 0.00001 par value; 10,000,000 shares authorized; no shares issued and outstanding at december 31, 2019 and december 31, 2018, respectively
    		                                
      preferred stock, 0.00001 par value; 10,000,000 shares authorized; no shares issued and outstanding at september 30, 2019 and december 31, 2018, respectively
    		                                
      accounts payable and accrued expenses
    		                         22,074,000       
      preferred stock, 0.00001 par value; 10,000,000 shares authorized; no shares issued and outstanding at june 30, 2019 and december 31, 2018, respectively
    		                                
      contingent royalty obligation payable to evolus founders, a related party
    		                          45,900,000 50,200,000 51,100,000 48,800,000   
      contingent promissory note payable to evolus founders, a related party
    		                          17,153,000 16,904,000 16,791,000 16,470,000   
      preferred stock, 0.00001 par value; 10,000,000 shares authorized; no shares issued and outstanding at march 31, 2019 and december 31, 2018, respectively
    		                                
      cash
    		                           93,162,000 105,168,000 43,585,000   
      related party receivable
    		                               72,639,000 
      intangible asset
    		                           56,076,000 56,076,000 56,076,000 56,076,000 56,076,000 
      related party borrowings
    		                               72,639,000 
      note obligation
    		                               138,687,000 
      convertible series a preferred, 0.00001 par value; no shares authorized; 0 and 1,250,000 shares issued and outstanding at december 31, 2018 and december 31, 2017, respectively
    		                                
      preferred stock, 0.00001 par value; 10,000,000 shares authorized; no shares issued and outstanding at december 31, 2018 and december 31, 2017, respectively
    		                                
      convertible series a preferred, 0.00001 par value; no shares authorized; 0 and 1,250,000 shares issued and outstanding at september 30, 2018 and december 31, 2017, respectively
    		                                
      preferred stock, 0.00001 par value; 10,000,000 shares authorized; no shares issued and outstanding at september 30, 2018 and december 31, 2017, respectively
    		                                
      convertible series a preferred, 0.00001 par value; no shares authorized; 0 and 1,250,000 shares issued and outstanding at june 30, 2018 and december 31, 2017, respectively
    		                                
      preferred stock, 0.00001 par value; 10,000,000 shares authorized; no shares issued and outstanding at june 30, 2018 and december 31, 2017, respectively
    		                                
      related party accounts payable
    		                              730,000  
      contingent royalty obligation payable to related party
    		                              40,600,000  
      contingent promissory note payable to related party
    		                              16,149,000  
      convertible series a preferred, 0.00001 par value; no shares authorized; 0 and 1,250,000 shares issued and outstanding at march 31, 2018 and december 31, 2017, respectively
    		                                
      preferred stock, 0.00001 par value; 10,000,000 shares authorized; no shares issued and outstanding at march 31, 2018 and december 31, 2017, respectively
    		                                
      restricted cash
    		                                
      liabilities and stockholder’s deficit
    		                                
      stockholder’s deficit
    		                                
      convertible series a preferred, 0.00001 par value; 2,500,000 shares authorized; 1,250,000 shares issued and outstanding at december 31, 2017 and 2016
    		                                
      total stockholder’s deficit
    		                               -75,543,000 
      total liabilities and stockholder’s deficit
    		                               152,233,000 
      operating expenses:
    		                                
      research and development
    		                               6,689,000 
      general and administrative
    		                               4,819,000 
      depreciation and amortization
    		                               218,000 
      total operating expenses
    		                               11,726,000 
      income from operations
    		                               -11,726,000 
      other income:
    		                                
      other income
    		                               5,000 
      income before taxes
    		                               -11,731,000 
      benefit for income taxes
    		                               -7,251,000 
      net income and comprehensive loss
    		                               -4,480,000 
      net income per share
    		                               -270 
      weighted-average shares outstanding used to compute basic and diluted net income per share
    		                               16,527,000,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.